$NVDA NEWS Nvidia stock hits another record as Wall Street stays bullish NasdaqGS - Nasdaq Real Time Price ? USD MeiraGTx Holdings plc (MGTX) Follow Compare 5.99 -0.15 (-2.44%) At close: 4:00 PM EDT 5.99 0.00 (0.00%) After hours: 4:02 PM EDT All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations High Growth Tech Stocks to Watch in October 2024 The United States market has remained flat over the last week but is up 38% over the past year with earnings expected to grow by 15% annually. In this context, high growth tech stocks that exhibit robust innovation and scalability potential are particularly noteworthy as they can capitalize on these favorable economic conditions. Simply Wall St. ? 6 hours ago CXT MGTX -2.44% TBLA MeiraGTx’s Parkinson’s gene therapy shows promise in Phase I/II study The AAV-GAD bridging study met the primary endpoint of safety and tolerability, and showed early promise in Parkinson’s patients. Clinical Trials Arena ? 5 days ago MGTX -2.44% MGTX Stock Up on Upbeat Efficacy Data From Parkinson's Disease Study MeiraGTx stock rises 15% as gene therapy candidate betters sham treatment in Parkinson's disease patients. Zacks ? 5 days ago MGTX -2.44% MeiraGTx Holdings Reports Promising Parkinson’s Therapy Results The latest announcement is out from Meiragtx Holdings ( (MGTX) ). MeiraGTx Holdings has unveiled promising results from its clinical bridging study of AAV-GAD, a gene therapy for Parkinson’s disease, showcasing significant improvements in both motor function and quality of life. The study demonstrated an 18-point average improvement in motor scores for the high dose group and noted meaningful enhancements in patient-reported outcomes, with no serious adverse events reported. This progress paves TipRanks ? 5 days ago MGTX -2.44% MeiraGTx (MGTX) Surges 14.9%: Is This an Indication of Further Gains? MeiraGTx (MGTX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term. Zacks ? 5 days ago MGTX -2.44% MRUS Small Cap-MeiraGTx Reveals Encouraging Data From Parkinson's Study Showing Significant, Clinically Meaningful Changes in Key Efficacy Endpoints On Tuesday, MeiraGTx Holdings plc (NASDAQ:MGTX) released topline data from its clinical bridging study of AAV-GAD for Parkinson’s disease, MGT-GAD-025. MGT-GAD-025 is a 6-month, three-arm, randomized, double-blind, sham-controlled study using AAV-GAD drug product manufactured by MeiraGTx at its wholly-owned facilities with its commercial platform process. Participants had idiopathic Parkinson’s disease, a history of levodopa responsiveness for at least 12 months, and a UPDRS Part 3 score of ≥25 Benzinga ? 6 days ago MGTX -2.44% MeiraGTx Announces Positive Data from Randomized, Sham-controlled Clinical Bridging Study of AAV-GAD for the Treatment of Parkinson’s Disease The primary study objective of safety and tolerability was met Significant and clinically meaningful improvements from baseline demonstrated for key efficacy endpoints at 26 weeks Significant improvement of 18 points in Unified Parkinson’s Disease Rating Scale (UPDRS) Part 3 in the high dose group at 26 weeks Significant improvement in the Parkinson’s Disease Questionnaire (PDQ-39) score, a key quality of life measure, for both the high and low dose groups at 26 weeks LONDON and NEW YORK, Oct. 1 GlobeNewswire ? 6 days ago MGTX -2.44% MeiraGTx Announces Poster Presentation on a Potential Treatment for MC4R Genetic Deficiency at the 2024 Society for Neuroscience Conference Results indicate a potent and effective locally delivered AAV-BDNF gene therapy for the treatment of obesity caused by MC4R deficiencyLONDON and NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic medicine company, today announced a poster presentation at the 2024 Society for Neuroscience Conference (SfN), which is being held from October 5-9, 2024, in Chicago, IL. “We are pleased to share data at this year’s Society f GlobeNewswire ? 12 days ago MGTX -2.44% MeiraGTx Holdings plc's (NASDAQ:MGTX) Profit Outlook With the business potentially at an important milestone, we thought we'd take a closer look at MeiraGTx Holdings plc's... Simply Wall St. ? 14 days ago MGTX -2.44% Harmony Biosciences (HRMY) Surges 6.7%: Is This an Indication of Further Gains? Harmony Biosciences (HRMY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term. Zacks ? 24 days ago HRMY MGTX -2.44% Exploring Three High Growth Tech Stocks in the United States Over the last 7 days, the market has dropped 4.4%, yet in the last year, it is up 19%, with earnings forecast to grow by 15% annually. In this dynamic environment, identifying high growth tech stocks that align with these trends can be crucial for investors seeking robust opportunities in the United States market. Simply Wall St. ? last month HRTX MGTX -2.44% DSP Is MeiraGTx Holdings plc (MGTX) The Best Rated Penny Stock To Buy According to Analysts? We recently published a list of 10 Best Rated Penny Stocks To Buy According to Analysts. In this article, we are going to take a look at where MeiraGTx Holdings plc (NASDAQ:MGTX) stands against the other best rated penny stocks. Penny stocks, often defined as shares trading for less than $5, present a high-risk, high-reward investment […] Insider Monkey ? last month MGTX -2.44% MeiraGTx Holdings PLC (MGTX) Reports Q2 Loss, Lags Revenue Estimates MeiraGTx (MGTX) delivered earnings and revenue surprises of -145.16% and 98.28%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock? Zacks ? 2 months ago MGTX -2.44% MeiraGTx Announces $50 Million Offering of Ordinary Shares led by Sanofi and Reports Second Quarter 2024 Financial and Operational Results - Positive data from the Phase 1 AQUAx study in radiation-induced xerostomia (RIX) presented at the American Academy of Oral Medicine 2024 annual meeting (AAOM) showed meaningful improvements in patient-reported outcomes and saliva production with AAV2-hAQP1 treatment - Company awarded Innovation Passport Designation by the U.K. Innovative Licensing and Access Pathway Steering Group for AAV8-RK-AIPL1 for the treatment of AIPL1-Leber congenital amaurosis 4 (LCA4) LONDON and NEW YORK, Aug. 12, 202 GlobeNewswire ? 2 months ago MGTX -2.44% MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by Sanofi LONDON and NEW YORK, Aug. 12, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic medicine company, today announced the pricing of an underwritten offering of 12,500,000 of its ordinary shares at an offering price of $4.00 per share. Gross proceeds to MeiraGTx from the offering are expected to be $50 million, before deducting underwriting discounts and commissions and offering expenses. All of the ordinary shares in the offering are bein GlobeNewswire ? 2 months ago MGTX -2.44% MeiraGTx Holdings (NASDAQ:MGTX) investors are sitting on a loss of 86% if they invested five years ago Long term investing is the way to go, but that doesn't mean you should hold every stock forever. We don't wish... Simply Wall St. ? 3 months ago MGTX -2.44% Here's Why It's Unlikely That MeiraGTx Holdings plc's (NASDAQ:MGTX) CEO Will See A Pay Rise This Year Key Insights MeiraGTx Holdings will host its Annual General Meeting on 6th of June CEO Alexandria Forbes' total... Simply Wall St. ? 4 months ago MGTX -2.44% Ireland – the jewel in the life sciences crown? Business in the Emerald Isle is booming as the life science industry expands across key clusters in the country. Medical Device Network ? 4 months ago REGN MGTX -2.44% Analyst Forecasts For MeiraGTx Holdings plc (NASDAQ:MGTX) Are Surging Higher MeiraGTx Holdings plc ( NASDAQ:MGTX ) shareholders will have a reason to smile today, with the analysts making... Simply Wall St. ? 5 months ago MGTX -2.44% MeiraGTx Holdings PLC Reports First Quarter 2024 Financial Results Performance Aligns with Analyst Projections Amidst Strategic Clinical Advancements GuruFocus.com ? 5 months ago MGTX -2.44% Performance Overview Trailing total returns as of 10/21/2024, which may include dividends or other distributions. Benchmark is S&P 500 Return MGTX S&P 500 YTD -14.67% +22.73% 1-Year +60.16% +38.58% 3-Year -71.46% +29.05%
